Westwind Capital Sells 1,610 Shares of Intuitive Surgical, Inc. $ISRG

Westwind Capital decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 21,072 shares of the medical equipment provider’s stock after selling 1,610 shares during the quarter. Intuitive Surgical accounts for 2.1% of Westwind Capital’s holdings, making the stock its 17th largest position. Westwind Capital’s holdings in Intuitive Surgical were worth $8,569,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. State Street Corp grew its position in Intuitive Surgical by 1.0% during the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after buying an additional 162,264 shares in the last quarter. Invesco Ltd. raised its holdings in Intuitive Surgical by 17.4% in the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares in the last quarter. Bank of America Corp DE raised its holdings in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $1,335,753,000. Finally, Amundi lifted its position in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Multiple analyst endorsements support investor sentiment. Piper Sandler issued a Buy rating, while Barclays upgraded Intuitive Surgical to Strong Buy after initiating coverage at Overweight. Citi had also assigned a Buy rating. These actions suggest analysts view the company as a high-quality medical-device leader despite a softer industry backdrop. Piper Sandler Buy rating Barclays coverage
• Positive Sentiment: Growth in the da Vinci SP platform is a key catalyst. Rising procedure volumes, system utilization and placements, along with expanding indications and international adoption, could make the single-port platform an important future revenue franchise. Single-port platform growth
• Positive Sentiment: Investors are anticipating further operating growth. Analysts expect year-over-year increases in earnings and revenue ahead of Intuitive Surgical’s October 20 earnings release. The company’s latest reported quarter already exceeded consensus earnings and revenue estimates. Barclays bullish initiation
• Neutral Sentiment: Analyst optimism should be viewed cautiously. Intuitive Surgical’s favorable average brokerage recommendation may be supportive, but sell-side ratings can be overly optimistic and the stock’s elevated valuation leaves less room for disappointing results. Analyst recommendation analysis
• Negative Sentiment: Competition remains the principal risk. Commentary from Jim Cramer highlighted increasing competition, particularly from Johnson & Johnson, raising concerns that rivals could pressure Intuitive Surgical’s dominant position and valuation. Competition commentary

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $0.89 during trading on Thursday, reaching $415.41. The stock had a trading volume of 2,530,203 shares, compared to its average volume of 2,423,688. The stock has a market capitalization of $146.76 billion, a PE ratio of 47.58, a P/E/G ratio of 3.05 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The business’s 50-day moving average price is $384.95 and its 200 day moving average price is $411.17.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the company earned $1.81 EPS. Intuitive Surgical’s revenue for the quarter was up 18.4% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Mizuho set a $500.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. reduced their target price on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research report on Friday, July 17th. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research note on Thursday, July 30th. Wells Fargo & Company reissued an “overweight” rating and issued a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Finally, Stifel Nicolaus lowered their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $502.53.

Insider Buying and Selling

In other Intuitive Surgical news, VP Fredrik Widman sold 1,089 shares of the stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the sale, the vice president owned 1,026 shares of the company’s stock, valued at $384,175.44. This represents a 51.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the executive vice president owned 5,320 shares of the company’s stock, valued at $2,016,280. The trade was a 6.99% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 in the last 90 days. 0.60% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.